Surliv 150 mg (Tablet)

Unit Price: ৳ 15.00 (2 x 10: ৳ 300.00)
Strip Price: ৳ 150.00

Medicine Details

Category Details
Generic Ursodeoxycholic acid
Company Eskayef pharmaceuticals ltd
Also available as

Indications

  • Cholestasis (Jaundice)
  • Viral Hepatitis
  • Alcoholic Fatty Liver
  • Primary Billiary Cirrhosis (PBC)
  • Primary Sclerosing Cholangitis (PSC)
  • Dissolution of Gallstones
  • Non-Alcoholic Steato Hepatitis (NASH)

Description

  • Reduces cholesterol saturation of bile
  • Promotes the dissolution of gallstones
  • Reduces cholesterol secretion into bile
  • Increases bile acid secretion rate

Pharmacology

  • Decreases secretion of cholesterol in bile
  • Reduces cholesterol absorption
  • Suppresses liver cholesterol synthesis
  • Promotes formation of liquid cholesterol crystal complexes
  • Enhances removal of cholesterol from gallbladder
  • Protects cholangiocytes against cytotoxicity
  • Stimulates hepatobilliary secretion
  • Protects hepatocytes against bile acid-induced apoptosis
  • Completely absorbed in the upper intestine
  • Peak serum concentration varies from 30 to 150 minutes
  • Absorption rate ranges from 60-80%
  • Enters the portal vein and undergoes extraction from portal blood by liver
  • Conjugated with amino acid (glycine or taurine)
  • Excreted into hepatic bile ducts
  • Appears in the circulation in small quantities
  • Biologic half-life ranges from 3.5-5.8 days

Dosage & Administration

  • Dissolution of Gall stones: 8-12 mg/kg/day
  • Primary Billiary Cirrhosis: 10-15 mg/kg/day
  • Acute Viral Hepatitis: 600 mg/day
  • Alcoholic Fatty Liver: 300 mg/day
  • Primary Sclerosing Cholangitis: 25-30 mg/kg/day
  • Dissolution of Gallstones and Non-Alcoholic Steato Hepatitis: 13-15 mg/kg/day

Interaction

  • Should not be used with oestrogenic hormones
  • Avoid concomitant administration with bile-acid binding drugs

Contraindications

  • Non-functioning gall-bladder
  • Calcified and pigmented gallstones
  • Inflammatory bowel disease

Side Effects

  • Nausea
  • Vomiting
  • Diarrhoea
  • Gallstone opacilication
  • Pruritus

Pregnancy & Lactation

  • Pregnancy category B
  • No evidence of harm reported in pregnancy
  • Effectively used for the treatment of cholestasis of pregnancy
  • Problems not documented regarding breastfeeding

Precautions & Warnings

  • Use cautiously in those with liver disease

Therapeutic Class

  • Anti-gallstones drugs: Bile Acids

Storage Conditions

  • Store below 25°C
  • Protected from light and moisture
  • Keep medicine out of the reach of children

Related Brands